COLTÉNE/WHALEDENT INC. – Trademark Portfolio
Entity Type: 03
COLTÉNE/WHALEDENT INC. owns a portfolio of 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as MP-US, DENTRONIX, and ULTRONICS. Of these, 4 are registered. The portfolio spans 6 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). Headquartered in CUYAHOGA FALLS, OH.
235 ASCOT PARKWAY
CUYAHOGA FALLS, OH 44223
Showing of trademarks Trademarks
Trademark Classifications
COLTÉNE/WHALEDENT INC.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does COLTÉNE/WHALEDENT INC. have?
COLTÉNE/WHALEDENT INC. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 cancelled.
What trademark classes does COLTÉNE/WHALEDENT INC. file in?
COLTÉNE/WHALEDENT INC. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 9 (Computers & Electronics), Class 8 (Hand Tools). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are COLTÉNE/WHALEDENT INC.'s most well-known trademarks?
COLTÉNE/WHALEDENT INC.'s registered trademark portfolio includes well-known marks such as MP-US, DENTRONIX, and ULTRONICS. These are among 4 currently registered trademarks in the portfolio.
What is COLTÉNE/WHALEDENT INC.'s trademark registration success rate?
COLTÉNE/WHALEDENT INC. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.